GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Radiopharm Theranostics Ltd (ASX:RAD) » Definitions » Issuance of Stock

Radiopharm Theranostics (ASX:RAD) Issuance of Stock : A$29.65 Mil (TTM As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Radiopharm Theranostics Issuance of Stock?

Radiopharm Theranostics's Issuance of Stock for the six months ended in Dec. 2023 was A$2.11 Mil.

Radiopharm Theranostics's Issuance of Stock for the trailing twelve months (TTM) ended in Dec. 2023 was A$29.65 Mil.


Radiopharm Theranostics Issuance of Stock Historical Data

The historical data trend for Radiopharm Theranostics's Issuance of Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Radiopharm Theranostics Issuance of Stock Chart

Radiopharm Theranostics Annual Data
Trend Jun22 Jun23 Jun24
Issuance of Stock
70.00 10.07 29.65

Radiopharm Theranostics Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Issuance of Stock Get a 7-Day Free Trial 20.00 10.07 - 2.11 27.53

Radiopharm Theranostics Issuance of Stock Calculation

A company may raise cash from issuing new shares. Issuance of Stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Issuance of Stock for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$29.65 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Radiopharm Theranostics Issuance of Stock Related Terms

Thank you for viewing the detailed overview of Radiopharm Theranostics's Issuance of Stock provided by GuruFocus.com. Please click on the following links to see related term pages.


Radiopharm Theranostics Business Description

Traded in Other Exchanges
N/A
Address
62 Lygon Street, Level 3, Carlton South, Melbourne, VIC, AUS, 3053
Radiopharm Theranostics Ltd is a Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialisation of health technologies.

Radiopharm Theranostics Headlines

No Headlines